Scandinavian Medical Solutions AS is a provider of Medical Imaging equipment. The company specializes in the acquisition, quality check, and resale of high-quality pre-owned medical imaging systems. The company supplies value-added resellers and distributors in various countries with MRI, CT, PET/CT, and other diagnostic scanners. It operates the business through three business areas, Equipment Solutions, Parts Solutions and Rental Solutions. Equipment Solutions is the company's main source of revenue, which focuses on sourcing, inspecting, and selling imaging systems such as MRI, CT, PET/CT, Cath-Lab, and Mammography units.
2018
29
LTM Revenue $38.1M
LTM EBITDA $1.6M
$25.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of December 2025, Scandinavian Medical reported last 12-month revenue of $38.1M and EBITDA of $1.6M.
In the same period, Scandinavian Medical generated $5.3M in LTM gross profit.
See Scandinavian Medical valuation multiples based on analyst estimatesIn the most recent fiscal year, Scandinavian Medical reported revenue of $38.1M and EBITDA of $1.7M.
Scandinavian Medical expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Scandinavian Medical valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $38.1M | XXX | $38.1M | XXX | XXX | XXX |
| Gross Profit | $5.3M | XXX | $5.3M | XXX | XXX | XXX |
| Gross Margin | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA | $1.6M | XXX | $1.7M | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| EBIT | $0.3M | XXX | $0.3M | XXX | XXX | XXX |
| EBIT Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | n/a | XXX | $4K | XXX | XXX | XXX |
| Net Margin | n/a | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $3.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Scandinavian Medical has current market cap of DKK 104M (or $16.1M), and EV of DKK 165M (or $25.7M).
As of January 19, 2026, Scandinavian Medical's stock price is DKK 4 (or $1).
See Scandinavian Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $25.7M | $16.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialScandinavian Medical's trades at 0.7x EV/Revenue multiple, and 16.5x EV/EBITDA.
See valuation multiples for Scandinavian Medical and 15K+ public compsAs of January 19, 2026, Scandinavian Medical has market cap of $16.1M and EV of $25.7M.
Equity research analysts estimate Scandinavian Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Scandinavian Medical's P/E ratio is not available.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $16.1M | XXX | $16.1M | XXX | XXX | XXX |
| EV (current) | $25.7M | XXX | $25.7M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 16.5x | XXX | 16.5x | XXX | XXX | XXX |
| EV/EBIT | 82.6x | XXX | 82.6x | XXX | XXX | XXX |
| EV/Gross Profit | 4.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 3993.4x | XXX | XXX | XXX |
| EV/FCF | -4.7x | XXX | -4.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialScandinavian Medical's last 12 month revenue growth is -2%
Scandinavian Medical's revenue per employee in the last FY averaged $1.3M, while opex per employee averaged $0.2M for the same period.
Scandinavian Medical's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Scandinavian Medical's rule of X is -1% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Scandinavian Medical and other 15K+ public comps| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -2% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | -33% | XXX | XXX | XXX |
| Rule of 40 | 8% | XXX | 2% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -1% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Scandinavian Medical acquired XXX companies to date.
Last acquisition by Scandinavian Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Scandinavian Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Scandinavian Medical founded? | Scandinavian Medical was founded in 2018. |
| Where is Scandinavian Medical headquartered? | Scandinavian Medical is headquartered in Denmark. |
| How many employees does Scandinavian Medical have? | As of today, Scandinavian Medical has 29 employees. |
| Is Scandinavian Medical publicy listed? | Yes, Scandinavian Medical is a public company listed on CSE. |
| What is the stock symbol of Scandinavian Medical? | Scandinavian Medical trades under SMSMED ticker. |
| When did Scandinavian Medical go public? | Scandinavian Medical went public in 2021. |
| Who are competitors of Scandinavian Medical? | Similar companies to Scandinavian Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Scandinavian Medical? | Scandinavian Medical's current market cap is $16.1M |
| What is the current revenue of Scandinavian Medical? | Scandinavian Medical's last 12 months revenue is $38.1M. |
| What is the current revenue growth of Scandinavian Medical? | Scandinavian Medical revenue growth (NTM/LTM) is -2%. |
| What is the current EV/Revenue multiple of Scandinavian Medical? | Current revenue multiple of Scandinavian Medical is 0.7x. |
| Is Scandinavian Medical profitable? | Yes, Scandinavian Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Scandinavian Medical? | Scandinavian Medical's last 12 months EBITDA is $1.6M. |
| What is Scandinavian Medical's EBITDA margin? | Scandinavian Medical's last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of Scandinavian Medical? | Current EBITDA multiple of Scandinavian Medical is 16.5x. |
| What is the current FCF of Scandinavian Medical? | Scandinavian Medical's last 12 months FCF is -$5.4M. |
| What is Scandinavian Medical's FCF margin? | Scandinavian Medical's last 12 months FCF margin is -14%. |
| What is the current EV/FCF multiple of Scandinavian Medical? | Current FCF multiple of Scandinavian Medical is -4.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.